SEC Form 4 · accession 0001209191-17-042168
NEKTAR THERAPEUTICS · NKTR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joseph J Krivulka
Director
Period of report
Jun 26, 2017
Accepted (ET)
Jun 28, 2017 · 6:05 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000906709
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 26, 2017 | M | 15,000 | $8.37 | A | 73,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option | $8.37 | Jun 26, 2017 | M | 15,000 | D | Sep 15, 2010 | Sep 14, 2017 | Common Stock | 15,000 | 0 | D |